Your Source for Venture Capital and Private Equity Financings

Select An Article

Kernel Scoops Up $53M Series C Funding
2020-07-09
LOS ANGELES, CA, Kernel announced today the close of a $53 million Series C round of venture financing.
Read More
LogDNA Nabs $25M Series C Round
2020-07-09
MOUNTAIN VIEW, CA, LogDNA, the leading log management solution for DevOps teams, announced today that it has closed a $25 million series C round of funding.
Read More
Kindbody Secures $32M
2020-07-09
NEW YORK, NY, Kindbody has announced a $32 million Series B funding.
Read More
Tiff's Treats Lands $15M
2020-07-09
AUSTIN, TX, Tiff's Treats announced it has raised $15 million in a planned $10 million funding.
Read More
Docket Raises $1.25M
2020-07-09
INDIANAPOLIS, IN, Docket has secured $1.25 million in funding.
Read More
Perfect Day Scores $300M Series C
2020-07-09
BERKELEY, CA, Today, pioneering animal-free dairy maker, Perfect Day, announced the expansion of its Series C to $300 million.
Read More
Taulia Inks $60M Strategic Financing
2020-07-09
SAN FRANCISCO, CA, Taulia, the leader in working capital technology solutions, today announced a new strategic funding round of $60 million.
Read More
VelosBio Raises $137M in Series B
2020-07-09
SAN DIEGO, CA, VelosBio announced the completion of an oversubscribed Series B financing of $137 million led by Matrix Capital Management.
Read More
K4Connect Closes Additional $7.7M for Series B
2020-07-09
RALEIGH, NC, K4Connect has raised $7.7 million if new funding led by Georgia-based Forte Ventures.
Read More
Growers Edge Closes $40M Series B
2020-07-09
JOHNSTON, IA, Growers Edge Financial announced the close of a $40M Series B round of financing led by S2G Ventures, Cox Enterprises, and Skyline Global Partners.
Read More
InOrbit Lands $2.6M Seed Round
2020-07-09
MOUNTAIN VIEW, CA, InOrbit, the leading provider of cloud-based robot management software, today announced it has closed $2.6 million in seed round funding.
Read More
Tranquis Therapeutics Receives $30M Series A
2020-07-09
SAN MATEO, CA, Tranquis Therapeutics, a private immuno-neurology company, launched today with $30 million in Series A funding.
Read More